Alpha Centric Advisors LLC Alx Oncology Holdings Inc Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$8.23 - $15.14 $201,635 - $370,930
-24,500 Closed
0 $0
Q4 2021

Feb 25, 2022
BUY
$21.49 - $74.4 $526,505 - $1.82 Million
24,500 New
24,500 $527,000
Q1 2021

Mar 09, 2022
SELL
$62.84 - $87.68 $94,260 - $131,520
-1,500 Closed
0 $0
Q4 2020

Mar 11, 2022
BUY
$34.11 - $112.26 $49,459 - $162,777
1,450 Added 2900.0%
1,500 $129,000
Q3 2020

Mar 11, 2022
BUY
$29.36 - $47.1 $1,468 - $2,355
50 New
50 $2,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $74.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email